Question 1

What is Axsome Therapeutics?

Accepted Answer

Axsome Therapeutics is a Company.

Question 2

How often does Axsome Therapeutics appear in global news?

Accepted Answer

Tracked across 7 news events drawn from 47 articles.

Question 3

When was Axsome Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 01, 2026.

Question 4

When was Axsome Therapeutics last mentioned in news?

Accepted Answer

Last active on Jul 15, 2026.

Question 5

What is Axsome Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 16 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Axsome Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 7 events.

Question 7

What is the most recent event involving Axsome Therapeutics?

Accepted Answer

Axsome Therapeutics Supports Migraine Awareness (Jun 01, 2026, 6 articles).

Question 8

How did the "Axsome Therapeutics Supports Migraine Awareness" event impact Axsome Therapeutics?

Accepted Answer

Axsome Therapeutics is supporting educational initiatives during Migraine and Headache Awareness Month, which could positively impact its public image and potentially increase awareness of its migraine treatments.

Question 9

How did the "Axsome resolves SUNOSI patent litigation" event impact Axsome Therapeutics?

Accepted Answer

Axsome Therapeutics has resolved all patent litigation related to its product Solriamfetol, securing market exclusivity until at least March 2040, which is positive for its long-term revenue prospects.

Question 10

How did the "Axsome Presents SYMBRAVO Migraine Data" event impact Axsome Therapeutics?

Accepted Answer

Axsome Therapeutics presented new data for its Meloxicam/rizatriptan product at a scientific meeting, which could positively impact its market perception and future sales.

Question 11

How did the "Axsome Therapeutics Presents Sleep Data" event impact Axsome Therapeutics?

Accepted Answer

Axsome Therapeutics announced new data presentations for its sleep medicine portfolio, which could positively impact its product development and market position in CNS disorders.

Question 12

How did the "Axsome Initiates Solriamfetol ADHD Trial" event impact Axsome Therapeutics?

Accepted Answer

Axsome Therapeutics initiated the FOCUS-3 Phase 3 trial for solriamfetol in adolescents with ADHD, which could expand its product portfolio and market reach if successful.

Question 13

How did the "Axsome Q2 2026 earnings date set" event impact Axsome Therapeutics?

Accepted Answer

Axsome is the subject of the announcement; it will report Q2 2026 results and provide a business update.

Question 14

How did the "FDA accepts Axsome NDA for AXS-12" event impact Axsome Therapeutics?

Accepted Answer

Axsome Therapeutics is the sponsor of the NDA for AXS-12; FDA acceptance is a positive step toward potential approval, which could add a new revenue stream.

Question 15

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.